Health
Targeted therapies developed to reduce lung fibrosis – Medical Xpress
A new treatment option for lung fibrosis is being developed by Purdue University scientists. Lung fibrosis has been a concern for COVID-19 patients.
A new treatment option for lung fibrosis is being developed by Purdue University scientists. Lung fibrosis has been a concern for COVID-19 patients.
People with idiopathic pulmonary fibrosis (IPF) have a life expectancy of less than five years. Fibrotic diseases cause organ failure that lead to about 45% of all deaths in the United States. Existing therapies do little to slow progression.
Now, Philip S. Low, the Purdue Ralph C. Corley Distinguished Professor of Chemistry and Presidential Scholar…
-
General14 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News20 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General15 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News11 hours agoSerious traffic crash, Noosa – Sunshine Coast